CRISPR-Based Diagnostics Market : Size, Trends, and Growth Analysis 2032
The CRISPR-Based Diagnostics Market is emerging as a transformative segment within the global diagnostics industry, driven by the revolutionary capabilities of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology. Valued at US$ 3,102.33 million in 2024, the market is projected to grow at a robust CAGR of 16.93% from 2025 to 2032. This growth trajectory is fueled by increasing demand for accurate, rapid, and cost-effective diagnostic tools, along with the expanding applications of CRISPR beyond gene editing into point-of-care testing and infectious disease detection.
The CRISPR-based diagnostic approach utilizes CRISPR-associated (Cas) proteins to identify and target specific DNA or RNA sequences, enabling highly precise detection of pathogens, genetic mutations, and other biomarkers. Unlike traditional methods, these diagnostics offer unparalleled sensitivity and speed, often delivering results in under an hour without the need for complex laboratory infrastructure.

https://analystviewmarketinsig....hts.com/reports/repo